Abstract: Under a settlement with regulators, the company must revamp some operations before resuming sales of its CPAP and ventilator devices in the United States.
Lead Paragraph:
Philips Respironics announced on Monday that it would halt sales of all of its breathing machines in the United States after reaching a settlement with the Food and Drug Administration over continuing problems with the devices.
Source: The New York Times
Category: Science
Sub Category:
2024-01-29T16:11:15+0000
By Christina Jewett